Keywords: gsk, valtrex, one-day, cold, sore, drug, glaxosmithkline
GSK's Valtrex could be one-day cold sore drug
Article | 12 August 2002
GlaxoSmithKline's orally-active antiviral Valtrex (valacyclovir HCl)may provide a one-day therapy for people who suffer from cold sores, according to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
